An on-line lead preconcentration and determination system implemented with inductively coupled plasma atomic emission spectrometry (ICP-AES) associated to flow injection (FI) with ultrasonic nebulization (USN) was studied. For the retention of lead, 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol (5-Br-PADAP) and Amberlite XAD-16 were used, at pH 9.2. The lead was removed from the microcolumn in counter flow with nitric acid. A total enhancement factor of 150 was obtained with respect to ICP-AES using pneumatic nebulization (15.0 for USN and 10.0 for column). The detection limit value for the preconcentration of 10 mL of aqueous solution of Pb was 0.2 ng mL−1. The precision for 10 replicate determinations at the 5 ng mL−1 Pb levels was 2.8% relative standard deviation (RSD), calculated with the peak heights obtained. The calibration graph using the preconcentration system for lead was linear with a correlation coefficient of 0.9997 at levels near the detection limits up to at least 100 ng mL−1. The method was successfully applied to the determination of lead in drinking water samples.
No takes yet. Share an insight, caveat, or question.
Wuilloud et al. (2002) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: